rs142063194

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2

The NM_144687.4(NLRP12):​c.969T>G​(p.Leu323Leu) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0106 in 1,613,942 control chromosomes in the GnomAD database, including 144 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0080 ( 9 hom., cov: 31)
Exomes 𝑓: 0.011 ( 135 hom. )

Consequence

NLRP12
NM_144687.4 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: -1.77

Publications

3 publications found
Variant links:
Genes affected
NLRP12 (HGNC:22938): (NLR family pyrin domain containing 12) This gene encodes a member of the CATERPILLER family of cytoplasmic proteins. The encoded protein, which contains an N-terminal pyrin domain, a NACHT domain, a NACHT-associated domain, and a C-terminus leucine-rich repeat region, functions as an attenuating factor of inflammation by suppressing inflammatory responses in activated monocytes. Mutations in this gene cause familial cold autoinflammatory syndrome type 2. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Mar 2013]
NLRP12 Gene-Disease associations (from GenCC):
  • familial cold autoinflammatory syndrome 2
    Inheritance: AD Classification: STRONG, MODERATE, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics, Orphanet, Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-1.0).
BP6
Variant 19-53810690-A-C is Benign according to our data. Variant chr19-53810690-A-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262533.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.77 with no splicing effect.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.008 (1217/152118) while in subpopulation NFE AF = 0.0133 (901/67978). AF 95% confidence interval is 0.0125. There are 9 homozygotes in GnomAd4. There are 556 alleles in the male GnomAd4 subpopulation. Median coverage is 31. This position passed quality control check.
BS2
High AC in GnomAd4 at 1217 AD gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP12NM_144687.4 linkc.969T>G p.Leu323Leu synonymous_variant Exon 3 of 10 ENST00000324134.11 NP_653288.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP12ENST00000324134.11 linkc.969T>G p.Leu323Leu synonymous_variant Exon 3 of 10 1 NM_144687.4 ENSP00000319377.6
NLRP12ENST00000345770.9 linkc.969T>G p.Leu323Leu synonymous_variant Exon 3 of 9 1 ENSP00000341428.5
NLRP12ENST00000391772.1 linkc.969T>G p.Leu323Leu synonymous_variant Exon 3 of 7 1 ENSP00000375652.1

Frequencies

GnomAD3 genomes
AF:
0.00801
AC:
1217
AN:
152000
Hom.:
9
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00198
Gnomad AMI
AF:
0.00330
Gnomad AMR
AF:
0.00447
Gnomad ASJ
AF:
0.0156
Gnomad EAS
AF:
0.000387
Gnomad SAS
AF:
0.00623
Gnomad FIN
AF:
0.00604
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.0133
Gnomad OTH
AF:
0.00621
GnomAD2 exomes
AF:
0.00859
AC:
2159
AN:
251284
AF XY:
0.00891
show subpopulations
Gnomad AFR exome
AF:
0.00191
Gnomad AMR exome
AF:
0.00494
Gnomad ASJ exome
AF:
0.0167
Gnomad EAS exome
AF:
0.0000544
Gnomad FIN exome
AF:
0.00407
Gnomad NFE exome
AF:
0.0124
Gnomad OTH exome
AF:
0.00946
GnomAD4 exome
AF:
0.0109
AC:
15887
AN:
1461824
Hom.:
135
Cov.:
40
AF XY:
0.0110
AC XY:
7972
AN XY:
727218
show subpopulations
African (AFR)
AF:
0.00176
AC:
59
AN:
33478
American (AMR)
AF:
0.00479
AC:
214
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.0161
AC:
420
AN:
26136
East Asian (EAS)
AF:
0.0000756
AC:
3
AN:
39700
South Asian (SAS)
AF:
0.00825
AC:
712
AN:
86256
European-Finnish (FIN)
AF:
0.00453
AC:
242
AN:
53388
Middle Eastern (MID)
AF:
0.00381
AC:
22
AN:
5768
European-Non Finnish (NFE)
AF:
0.0122
AC:
13588
AN:
1111980
Other (OTH)
AF:
0.0104
AC:
627
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.483
Heterozygous variant carriers
0
1037
2074
3110
4147
5184
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
480
960
1440
1920
2400
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00800
AC:
1217
AN:
152118
Hom.:
9
Cov.:
31
AF XY:
0.00748
AC XY:
556
AN XY:
74378
show subpopulations
African (AFR)
AF:
0.00197
AC:
82
AN:
41526
American (AMR)
AF:
0.00446
AC:
68
AN:
15246
Ashkenazi Jewish (ASJ)
AF:
0.0156
AC:
54
AN:
3472
East Asian (EAS)
AF:
0.000388
AC:
2
AN:
5160
South Asian (SAS)
AF:
0.00623
AC:
30
AN:
4812
European-Finnish (FIN)
AF:
0.00604
AC:
64
AN:
10604
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.0133
AC:
901
AN:
67978
Other (OTH)
AF:
0.00614
AC:
13
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
64
128
191
255
319
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0117
Hom.:
5
Bravo
AF:
0.00723
Asia WGS
AF:
0.00289
AC:
10
AN:
3478
EpiCase
AF:
0.0109
EpiControl
AF:
0.0102

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Familial cold autoinflammatory syndrome 2 Benign:2
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 20, 2024
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
May 01, 2025
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

NLRP12: BP4, BP7, BS1, BS2 -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Autoinflammatory syndrome Benign:1
Jan 14, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Familial cold autoinflammatory syndrome Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-1.0
CADD
Benign
0.58
DANN
Benign
0.40
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs142063194; hg19: chr19-54313944; API